• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Synthesis, pharmacological evaluations, and molecular docking studies on a new 1,3,4,11b-tetrahydro-1H-fluoreno[9,1-cd]azepine framework: Rigidification of D receptor selective 1-phenylbenzazepines and discovery of a new 5-HT receptor scaffold.新型 1,3,4,11b-四氢-1H-茚并[9,1-cd]氮杂卓骨架的合成、药理学评价和分子对接研究:D 受体选择性 1-苯基苯并氮杂卓的刚性化和 5-HT 受体支架的发现。
Chem Biol Drug Des. 2020 Aug;96(2):825-835. doi: 10.1111/cbdd.13691. Epub 2020 Apr 22.
2
Receptor affinities of dopamine D1 receptor-selective novel phenylbenzazepines.多巴胺D1受体选择性新型苯基苯并氮杂䓬类化合物的受体亲和力。
Eur J Pharmacol. 2003 Aug 8;474(2-3):137-40. doi: 10.1016/s0014-2999(03)02008-9.
3
Synthesis and evaluation of 6,7-dihydroxy-2,3,4,8,9,13b-hexahydro-1H- benzo[6,7]cyclohepta[1,2,3-ef][3]benzazepine, 6,7-dihydroxy- 1,2,3,4,8,12b-hexahydroanthr[10,4a,4-cd]azepine, and 10-(aminomethyl)-9,10- dihydro-1,2-dihydroxyanthracene as conformationally restricted analogs of beta-phenyldopamine.
J Med Chem. 1995 Jun 23;38(13):2395-409. doi: 10.1021/jm00013a015.
4
(+/-)-3-[4'-(N,N-dimethylamino)cinnamyl]benzazepine analogs: novel dopamine D1 receptor antagonists.(±)-3-[4'-(N,N-二甲基氨基)肉桂基]苯并氮杂卓类似物:新型多巴胺D1受体拮抗剂。
J Med Chem. 1996 Aug 16;39(17):3423-8. doi: 10.1021/jm960143p.
5
(+/-)-3-Allyl-6-bromo-7,8-dihydroxy-1-phenyl-2,3,4,5-tetrahydro-1H-3- benzazepin, a new high-affinity D1 dopamine receptor ligand: synthesis and structure-activity relationship.
J Med Chem. 1991 Dec;34(12):3366-71. doi: 10.1021/jm00116a004.
6
Catalepsy-associated behavior induced by dopamine D1 receptor antagonists and partial dopamine D1 receptor agonists in squirrel monkeys.松鼠猴中多巴胺D1受体拮抗剂和部分多巴胺D1受体激动剂诱导的僵住相关行为
Eur J Pharmacol. 1994 Aug 1;260(2-3):237-41. doi: 10.1016/0014-2999(94)90343-3.
7
A study on the contribution of the 1-phenyl substituent to the molecular electrostatic potentials of some benzazepines in relation to selective dopamine D-1 receptor activity.一项关于1-苯基取代基对某些苯并氮杂䓬类化合物分子静电势的贡献及其与选择性多巴胺D-1受体活性关系的研究。
J Med Chem. 1992 Feb 7;35(3):502-7. doi: 10.1021/jm00081a010.
8
CoMFA-based prediction of agonist affinities at recombinant D1 vs D2 dopamine receptors.基于比较分子力场分析(CoMFA)对重组D1和D2多巴胺受体激动剂亲和力的预测
J Med Chem. 1998 Oct 22;41(22):4385-99. doi: 10.1021/jm9800292.
9
Differential activation of adenylate cyclase and receptor internalization by novel dopamine D1 receptor agonists.新型多巴胺D1受体激动剂对腺苷酸环化酶的差异激活及受体内化作用
Mol Pharmacol. 2005 Oct;68(4):1039-48. doi: 10.1124/mol.105.012153. Epub 2005 Jun 28.
10
(+/-)-3-allyl-7-halo-8-hydroxy-1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepines as selective high affinity D1 dopamine receptor antagonists: synthesis and structure-activity relationship.
J Med Chem. 1992 Jan;35(1):67-72. doi: 10.1021/jm00079a008.

本文引用的文献

1
A new serotonin 5-HT receptor antagonist with procognitive activity - Importance of a halogen bond interaction to stabilize the binding.一种具有认知增强活性的新型血清素 5-HT 受体拮抗剂——卤键相互作用对稳定结合的重要性。
Sci Rep. 2017 Jan 24;7:41293. doi: 10.1038/srep41293.
2
Differential effects of dopamine-directed treatments on cognition.多巴胺导向治疗对认知的不同影响。
Neuropsychiatr Dis Treat. 2015 Jul 29;11:1859-75. doi: 10.2147/NDT.S65875. eCollection 2015.
3
Therapeutic Potential of 5-HT6 Receptor Agonists.5-HT6 受体激动剂的治疗潜力。
J Med Chem. 2015 Oct 22;58(20):7901-12. doi: 10.1021/acs.jmedchem.5b00179. Epub 2015 Jul 2.
4
Serotonin 5-HT6 receptor antagonists for the treatment of cognitive deficiency in Alzheimer's disease.用于治疗阿尔茨海默病认知缺陷的5-羟色胺5-HT6受体拮抗剂
J Med Chem. 2014 Sep 11;57(17):7160-81. doi: 10.1021/jm5003952. Epub 2014 Jun 3.
5
Structural basis for molecular recognition at serotonin receptors.血清素受体分子识别的结构基础。
Science. 2013 May 3;340(6132):610-4. doi: 10.1126/science.1232807. Epub 2013 Mar 21.
6
A New Route to Azafluoranthene Natural Products via Direct Arylation.通过直接芳基化合成氮杂荧蒽天然产物的新途径。
European J Org Chem. 2013 Feb 1;3013(6):1107-1115. doi: 10.1002/ejoc.201201190. Epub 2013 Jan 3.
7
Assessment of dopamine D₁ receptor affinity and efficacy of three tetracyclic conformationally-restricted analogs of SKF38393.评估三种 SKF38393 的四环构象受限类似物的多巴胺 D₁ 受体亲和力和效能。
Bioorg Med Chem. 2011 Sep 15;19(18):5420-31. doi: 10.1016/j.bmc.2011.07.057. Epub 2011 Aug 3.
8
Synthesis of C-Homoaporphines via Microwave-Assisted Direct Arylation.通过微波辅助直接芳基化合成C-高阿朴啡类化合物。
Tetrahedron. 2011 Jan 21;67(3):569-575. doi: 10.1016/j.tet.2010.11.059.
9
The medicinal chemistry of 5-HT6 receptor ligands with a focus on arylsulfonyltryptamine analogs.5-HT6 受体配体的药物化学研究——以芳基磺酰基色胺类似物为重点。
Curr Top Med Chem. 2010;10(5):579-95. doi: 10.2174/156802610791111542.
10
Microwave-Assisted Direct Biaryl Coupling: First Application to the Synthesis of Aporphines.微波辅助直接联芳基偶联:首次应用于阿朴啡类化合物的合成
Tetrahedron Lett. 2009 May 20;50(20):2437-2439. doi: 10.1016/j.tetlet.2009.03.029.

新型 1,3,4,11b-四氢-1H-茚并[9,1-cd]氮杂卓骨架的合成、药理学评价和分子对接研究:D 受体选择性 1-苯基苯并氮杂卓的刚性化和 5-HT 受体支架的发现。

Synthesis, pharmacological evaluations, and molecular docking studies on a new 1,3,4,11b-tetrahydro-1H-fluoreno[9,1-cd]azepine framework: Rigidification of D receptor selective 1-phenylbenzazepines and discovery of a new 5-HT receptor scaffold.

机构信息

Department of Chemistry, Hunter College, City University of New York, NY, USA.

Ph.D. Program in Chemistry, CUNY Graduate Center, New York, NY, USA.

出版信息

Chem Biol Drug Des. 2020 Aug;96(2):825-835. doi: 10.1111/cbdd.13691. Epub 2020 Apr 22.

DOI:10.1111/cbdd.13691
PMID:32279445
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7442682/
Abstract

The novel 1,3,4,11b-tetrahydro-1H-fluoreno[9,1-cd]azepine framework, a structurally rigidified variant of the 1-phenylbenzazepine template, was synthesized via direct arylation as a key reaction. Evaluation of the binding affinities of the rigidified compounds across a battery of serotonin, dopamine, and adrenergic receptors indicates that this scaffold unexpectedly has minimal affinity for D and other dopamine receptors and is selective for the 5-HT receptor. The affinity of these systems at the 5-HT receptor is significantly influenced by electronic and hydrophobic interactions as well as the enhanced rigidity of the ligands. Molecular docking studies indicate that the reduced D receptor affinity of the rigidified compounds may be due in part to weaker H-bonding interactions between the oxygenated moieties on the compounds and specific receptor residues. Key receptor-ligand H-bonding interactions, salt bridges, and π-π interactions appear to be responsible for the 5-HT receptor affinity of the compounds. Compounds 10 (6,7-dimethoxy-2,3,4,11b-tetrahydro-1H-fluoreno[9,1-cd]azepine) and 12 (6,7-dimethoxy-2-methyl-2,3,4,11b-tetrahydro-1H-fluoreno[9,1-cd]azepine) have been identified as structurally novel, high affinity (K  = 5 nM), selective 5-HT receptor ligands.

摘要

新型 1,3,4,11b-四氢-1H-氟萘并[9,1-cd]氮杂卓骨架,是苯并氮杂卓模板的结构刚性变体,通过直接芳基化作为关键反应进行合成。对刚性化合物在一系列血清素、多巴胺和肾上腺素能受体上的结合亲和力进行评估表明,该支架出人意料地对 D 和其他多巴胺受体几乎没有亲和力,而是对 5-HT 受体具有选择性。这些系统在 5-HT 受体上的亲和力受到电子和疏水性相互作用以及配体增强的刚性的显著影响。分子对接研究表明,刚性化合物对 D 受体亲和力降低可能部分是由于化合物上含氧部分与特定受体残基之间的氢键相互作用较弱。关键的受体-配体氢键相互作用、盐桥和 π-π 相互作用似乎是化合物对 5-HT 受体亲和力的原因。化合物 10(6,7-二甲氧基-2,3,4,11b-四氢-1H-氟萘并[9,1-cd]氮杂卓)和 12(6,7-二甲氧基-2-甲基-2,3,4,11b-四氢-1H-氟萘并[9,1-cd]氮杂卓)已被确定为具有结构新颖、高亲和力(K = 5 nM)和选择性的 5-HT 受体配体。